A Phase 3 clinical trial evaluating enfuvirtide status was updated on April 7, 2026. The trial, registered as NCT00302822 and titled "Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)," is listed with a status of completed.
The study examined enfuvirtide as an intensification therapy in treatment-naive individuals with HIV infection. According to the registry entry, the trial has reached completed status as of the listed date.
Enfuvirtide is categorized here under unapproved research status. No results, efficacy outcomes, or safety findings are included in this update. The registry entry reflects only the change in trial status and does not provide additional data on outcomes.
Further details on the trial design, enrollment, and any eventual results would be available through the official registry listing. Readers interested in the compound generally can consult the compound overview for additional context.